首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells
【24h】

Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells

机译:香豆素标记的1,3,4-二唑缀合物对MDA-MB-231和MCF-7人乳腺癌细胞的合成,计算研究和抗增殖活性

获取原文
获取原文并翻译 | 示例
           

摘要

A novel library of coumarin tagged 1,3,4 oxadiazole conjugates was synthesized and evaluated for their antiproliferative activities against MDA-MB-231 and MCF-7 breast cancer cell lines. The evaluation studies revealed that compound9dwas the most potent molecule with an IC50value of <5?μM against the MCF-7 cell line. Interestingly, compounds10band11ashowed a similar trend with lower inhibitory concentration (IC50?=?7.07?μM), in Estrogen Negative (ER?) cells than Estrogen Positive (ER+) cells. Structure–activity relationship (SAR) studies revealed that conjugates bearing benzyl moieties (9b,9cand9d) had superior activities compared to their alkyl analogues. The most potent compound9dshowed ~1.4?times more potent activity than tamoxifen against MCF-7 cell line; while the introduction of sulfone unit in compounds11a,11band11cresulted in significant cytotoxicity against both MCF-7 and MDA-MB-231 cell lines. These results were further supported by docking studies, which revealed that the stronger binding affinity of the synthesized conjugates is due to the presence of sulfone unit attached to the substituted benzyl moiety in their pharmacophores.
机译:合成并评估了对MDA-MB-231和MCF-7乳腺癌细胞系的抗增殖活动的合成和评估了Coumarin的一种新型香豆素库。评估研究表明,化合物9dwas最有效的分子,其IC50Value为<5Ωμm,对MCF-7细胞系列。有趣的是,化合物10band11ASHACHED具有较低的抑制浓度(IC50?=7.07μm)的类似趋势,在雌激素阴性(ERα)细胞中的雌激素阳性(ER +)细胞中。结构 - 活性关系(SAR)研究表明,与其烷基类似物相比,亚苄基部分(9B,9Cand9D)的缀合物具有优异的活性。最有效的化合物9d〜1.4?倍增的活性活动,而不是针对MCF-7细胞的毒素;虽然在化合物11a中引入砜单元,11band11在显着的细胞毒性下对MCF-7和MDA-MB-231细胞系进行了显着的细胞毒性。通过对接研究进一步支持这些结果,这表明合成缀合物的较强结合亲和力是由于其药委员中取代苄基部分上的砜单元存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号